Broach Lifecare Hospital Limited (BOM:544231)
India
· Delayed Price · Currency is INR 16.00
0.00 (0.00%)
At close: Apr 28, 2026
Broach Lifecare Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Operating Revenue | 39.75 | 31.79 | 26.06 | 18.16 | 33.92 | 36.64 |
| Other Revenue | -0 | - | - | - | - | 0 |
| Revenue | 39.75 | 31.79 | 26.06 | 18.16 | 33.92 | 36.64 |
| Revenue Growth (YoY) | 13.14% | 22.01% | 43.52% | -46.47% | -7.42% | - |
| Cost of Revenue | 19.42 | 15.78 | 9.8 | 7.16 | 15.78 | 22.22 |
| Gross Profit | 20.33 | 16.02 | 16.26 | 10.99 | 18.14 | 14.41 |
| Selling, General & Admin | 0.36 | 0.36 | 0.08 | - | - | - |
| Other Operating Expenses | 12.77 | 7.13 | 5.93 | 2.34 | 4.57 | 1.07 |
| Operating Expenses | 14.87 | 8.8 | 6.92 | 6.41 | 7.85 | 2.7 |
| Operating Income | 5.46 | 7.22 | 9.34 | 4.58 | 10.29 | 11.71 |
| Interest Expense | -0.62 | -0.26 | -0.01 | -2.46 | -0.86 | -1.4 |
| Interest & Investment Income | 0.46 | 0.46 | - | 0.09 | 0 | 0.01 |
| Other Non Operating Income (Expenses) | 0.38 | -0.01 | 0 | -0.23 | -0.02 | -0.01 |
| EBT Excluding Unusual Items | 5.68 | 7.4 | 9.33 | 1.99 | 9.42 | 10.32 |
| Other Unusual Items | - | - | - | -0.12 | -3.22 | 0.03 |
| Pretax Income | 5.68 | 7.4 | 9.33 | 1.87 | 6.2 | 10.34 |
| Income Tax Expense | 1.62 | 2.05 | 2.36 | 0.49 | 1.61 | 2.69 |
| Net Income | 4.06 | 5.36 | 6.98 | 1.39 | 4.59 | 7.65 |
| Net Income to Common | 4.06 | 5.36 | 6.98 | 1.39 | 4.59 | 7.65 |
| Net Income Growth | -55.71% | -23.18% | 403.68% | -69.83% | -40.00% | - |
| Shares Outstanding (Basic) | - | 5 | 4 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | - | 5 | 4 | 0 | 0 | 0 |
| Shares Change (YoY) | - | 22.11% | 24691.00% | - | - | - |
| EPS (Basic) | - | 0.98 | 1.56 | 76.94 | 255.06 | 425.11 |
| EPS (Diluted) | - | 0.98 | 1.56 | 76.94 | 255.06 | 425.11 |
| EPS Growth | - | -37.31% | -97.97% | -69.83% | -40.00% | - |
| Free Cash Flow | -3.1 | -10.23 | -46.97 | -28.32 | -17.63 | 1.14 |
| Free Cash Flow Per Share | - | -1.88 | -10.53 | -1573.44 | -979.33 | 63.56 |
| Gross Margin | 51.14% | 50.38% | 62.40% | 60.55% | 53.47% | 39.34% |
| Operating Margin | 13.73% | 22.70% | 35.86% | 25.25% | 30.34% | 31.97% |
| Profit Margin | 10.22% | 16.86% | 26.77% | 7.63% | 13.54% | 20.89% |
| Free Cash Flow Margin | -7.80% | -32.16% | -180.26% | -155.98% | -51.97% | 3.12% |
| EBITDA | 7.2 | 8.53 | 10.26 | 8.65 | 13.57 | 13.35 |
| EBITDA Margin | 18.12% | 26.82% | 39.37% | 47.66% | 40.00% | 36.43% |
| D&A For EBITDA | 1.74 | 1.31 | 0.92 | 4.07 | 3.28 | 1.63 |
| EBIT | 5.46 | 7.22 | 9.34 | 4.58 | 10.29 | 11.71 |
| EBIT Margin | 13.73% | 22.70% | 35.86% | 25.25% | 30.34% | 31.97% |
| Effective Tax Rate | 28.52% | 27.62% | 25.26% | 26.02% | 26.00% | 26.00% |
| Revenue as Reported | 40.6 | 32.25 | 26.06 | 19.25 | 34.77 | 38.02 |
| Advertising Expenses | - | 0 | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.